KRAS and neoplasm: Recently, UHRF1 was identified as a mediator of KRAS-driven lung cancer, whereby knockout of UHRF1 in KRAS mutant cells leads to reduced tumor growth and promotes apoptosis (Kostyrko et al. 2023).